Home > Drug Search >
  • company_query: Biopure Corporation
  •   > 
Drug Filter
Category:
chemistry (6) biology (29)
Status:
Approved (12) BLA Filing (1) Phase Ⅲ (6) Phase Ⅱ (9) Phase Ⅰ (7)
Clinical Stage:
Pending (5) Active (17) Discontinued (1)
Bio-Type:
Vaccine (7) Blood extraction (2) Microbial extract (3) Recombinant cytokines (5) Whole antibody (5) Fab fragment (1) Fusion protein (1)
Indication:
Anemia (2) Breast cancer (3) Poisoning (1) Guillain-Barre syndrome (1) Mucocutaneous lymph node syndrome (Kawasaki syndrome) (1) Community-acquired pneumonia (CAP) (1) Complicated intra-abdominal infection (1) Complicated urinary tract infection (1) Transplant rejection (1) wound (2) HBV infection (1) HCV infection (1) HIV infection (1) Hypertriglyceridemia (1) Glabellar line (1) Torticollis (1) Hepatitis A viral infection (1) Haemolytic disease of the newborn (1) Chronic inflammatory demyelinating polyradiculoneuropathy (1) Rabies (2) Lung cancer (1) Melanoma (2) Migraine (1) Multiple sclerosis (MS) (1) Obesity (1) Plantar fasciitis (1) Ovarian cancer (1) Overactive bladder (OAB) (1) Pneumonia (1) Viral infections (1) Prader-Willi syndrome (1) Tetanus (1) Rheumatoid arthritis (RA) (2) Varicella zoster virus infections (1) Solid tumours (1) Tuberculosis (1) Streptococcal infection (1) Venous thromboembolism (VTE) (1) Colorectal cancer (3) Rejection of renal transplantation (1) Ankylosing Spondylitis (AS) (1) Diabetic foot ulcers (1) Neutropenia (2) Condylomata acuminata (1) Renal carcinoma (1) Gram-positive bacterial infection (1) Clostridial infection (1) Plaque psoriasis (1) Burns (1) Diffuse large B cell lymphoma (1) Interstitial cystitis (1) Immunodeficiency disorders (2) Neurological disease (1) Skin disorders (1) Inflammation (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top